Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Rectal Neoplasms × atezolizumab × Clear all

Phase

Phase 2 3 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 11 Small Cell Lung Carcinoma 6 Lung Neoplasms 6 Carcinoma, Hepatocellular 6 Breast Neoplasms 6 Urinary Bladder Neoplasms 5 Carcinoma, Transitional Cell 5 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 Neoplasms 4 Neoplasm Metastasis 4 Melanoma 4 Glioblastoma 4 Advanced Solid Tumor 4 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Cancer 2 Small Cell Lung Cancer Extensive Stage 2 Sarcoma 2 Recurrence 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Leukemia, Myeloid, Acute 2 Gliosarcoma 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2

Interventions

Oxaliplatin 18 Fluorouracil 14 Capecitabine 14 Irinotecan 10 Radiotherapy 8 Leucovorin 8 Cetuximab 6 Bevacizumab 6 oblimersen 3 fludarabine 3 aldesleukin 3 Nivolumab 3 Gemcitabine 3 Erlotinib Hydrochloride 3 Cyclophosphamide 3 labetuzumab 2 dehydroftorafur 2 conatumumab 2 Receptor Protein-Tyrosine Kinases 2 Radiation 2 Panitumumab 2 Neoadjuvant Therapy 2 Gefitinib 2 Diphenhydramine 2 5,10-methylenetetrahydrofolic acid 2 sintilimab 1 sargramostim 1 rilotumumab 1 pertuzumab 1 pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03127007 2025-01-22

R-IMMUNE

Grand Hôpital de Charleroi

Phase 1/2 Completed

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡